Comparing virtual and in-person training for intracavernosal injection therapy in a multidisciplinary sexual health clinic within a prostate cancer survivorship program
DOI:
https://doi.org/10.5489/cuaj.9104Keywords:
erectile dysfunction, intracavernosal injection therapy, sexual rehabilitationAbstract
INTRODUCTION: The Sexual Health Clinic (SHC) offered by the Prostate Cancer Supportive Care (PCSC) Program delivers sexual health therapies for prostate cancer (PCa) patients and their partners. Since April 2020, training for using intracavernosal injections (ICI) to treat erectile dysfunction (ED) has been offered either in-person or by virtual appointments. This study’s primary objective was to assess the effectiveness of virtual compared to in-person ICI training by analyzing clinical and patient-reported outcomes (PROs) within each group.
METHODS: This is a retrospective, ethics-approved chart review of all patients who received ICI training between January 2019 and April 2023. PROs collected were obtained prospectively during routine clinical care. Outcomes, including PROs, satisfaction, and adverse events, were measured using surveys and validated questionnaires.
RESULTS: Over four years, 74 patients received ICI training, 54 virtually and 24 in-person. Each group’s demographics are similar with respect to age, education level, ethnicity, and partner information. Most patients had not attempted ICI before enrolling in the SHC and were not satisfied with other therapeutic options to treat their ED. Adherence was high in both groups. Virtual and in-person ICI teaching was similar with respect to clinical outcomes and satisfaction. Overall satisfaction was low in both groups. The frequency of adverse events was comparable.
CONCLUSIONS: Overall, clinical outcomes with ICI training in the virtual format do not appear to differ from those completed in person. Larger, prospective studies are needed to confirm these results.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:
- Post the Article on any Web site
- Translate or authorize a translation of the Article
- Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
- Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.
The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.
You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.
The CUA also requires you to warrant the following:
- That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
- That all individuals who have made a substantive contribution to the article are acknowledged;
- That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
- That the Article does not libel or violate the privacy rights of any third party.







